Keryx Biopharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | (57.5) | (52.2) | (25.8) |
| Net Investing Cash Flow | 27.9 | (51.9) | (13.2) |
| Net Financing Cash Flow | 0.0 | 84.7 | 77.4 |
| Net Change in Cash | (29.7) | (19.4) | 38.5 |
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 |
| Capital Expenditures | (3.2) | (7.6) | (1.0) |
| Cash Dividends Paid | -- | -- | -- |





